Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02480595Suspended

AAA Registry: Clinical Outcomes of Highly Angulated anatomY Treated With the Aorfix™ Stent Graft

Role: lead

NCT02907762Unknown

Aorfix Intelliflex First in Human Study

Role: lead

NCT00522535Not ApplicableCompleted

Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft

Role: lead

NCT00668681Not ApplicableWithdrawn

Evaluation of EndoRefix Endovascular Delivery System and Staple

Role: lead

NCT00442065Phase 2Completed

ARBITER-II: Aorfix™ Bifurcated Safety and Performance Trial: Phase II, Angulated Vessels

Role: lead

All 5 trials loaded